MARKET

SELB

SELB

Selecta Biosci
NASDAQ
1.050
0.000
0.00%
After Hours: 1.050 0 0.00% 16:53 05/26 EDT
OPEN
1.040
PREV CLOSE
1.050
HIGH
1.080
LOW
1.030
VOLUME
861.21K
TURNOVER
0
52 WEEK HIGH
2.730
52 WEEK LOW
0.6700
MARKET CAP
161.10M
P/E (TTM)
-10.8808
1D
5D
1M
3M
1Y
5Y
SNDL, Invitae among additions to Russell microcap; Inovio, Bionano among deletions
Seeking Alpha · 3d ago
HC Wainwright & Co. Reiterates Selecta Biosciences (SELB) Buy Recommendation
NASDAQ · 05/08 18:42
Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX), Selecta Biosciences (SELB) and Assembly Biosciences (ASMB)
TipRanks · 05/08 10:40
HC Wainwright & Co. Reiterates Buy on Selecta Biosciences, Maintains $5 Price Target
Benzinga · 05/08 10:39
Needham Reiterates Selecta Biosciences (SELB) Buy Recommendation
NASDAQ · 05/05 18:01
SVB Securities Remains a Buy on Selecta Biosciences (SELB)
TipRanks · 05/05 15:25
Needham Keeps Their Buy Rating on Selecta Biosciences (SELB)
TipRanks · 05/05 12:35
Needham Reiterates Buy on Selecta Biosciences, Maintains $5 Price Target
Benzinga · 05/05 09:31
More
About SELB
Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company leverages its ImmTOR platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses. It enables the re-dosing of life-saving gene therapies and restoring self-tolerance in autoimmune diseases. The ImmTOR platform reduces the formation of anti-drug antibodies (ADAs), against biologic drugs and restore self-tolerance to auto-antigens in autoimmune diseases. ImmTOR leverages nanoparticle technology to target rapamycin, an immunomodulatory drug, to antigen presenting cells to generate antigen-specific immune tolerance when combined with the antigen of interest. Its nanoparticles are designed to remain intact after injection into the body and accumulate predominantly in lymph nodes, the spleen, and the liver, where the immune response is coordinated. Its product candidate, SEL-212, which is in Phase III clinical development includes pegadricase, a pegylated uricase enzyme.

Webull offers kinds of Selecta Biosciences Inc stock information, including NASDAQ:SELB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SELB stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SELB stock methods without spending real money on the virtual paper trading platform.